Michael King - Net Worth and Insider Trading
Michael King Net Worth
The estimated net worth of Michael King is at least $1,460 dollars as of 2024-12-02. Michael King is the CHIEF FINANCIAL OFFICER of SAB Biotherapeutics Inc and owns about 500 shares of SAB Biotherapeutics Inc (SABS) stock worth over $1,460. Details can be seen in Michael King's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael King has not made any transactions after 2023-11-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Michael King
Michael King Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael King owns 1 companies in total, including SAB Biotherapeutics Inc (SABS) .
Click here to see the complete history of Michael King’s form 4 insider trades.
Insider Ownership Summary of Michael King
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SABS | SAB Biotherapeutics Inc | 2023-11-30 | CHIEF FINANCIAL OFFICER |
Michael King Latest Holdings Summary
Michael King currently owns a total of 1 stock. Michael King owns 500 shares of SAB Biotherapeutics Inc (SABS) as of November 30, 2023, with a value of $1,460.
Latest Holdings of Michael King
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SABS | SAB Biotherapeutics Inc | 2023-11-30 | 500 | 2.92 | 1,460 |
Holding Weightings of Michael King
Michael King Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael King has made a total of 1 transactions in SAB Biotherapeutics Inc (SABS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in SAB Biotherapeutics Inc is the acquisition of 500 shares on November 30, 2023, which cost Michael King around $4,500.
Insider Trading History of Michael King
- 1
Michael King Trading Performance
GuruFocus tracks the stock performance after each of Michael King's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael King is -54.63%. GuruFocus also compares Michael King's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael King within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Michael King's insider trading performs compared to the benchmark.
Performance of Michael King
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -29.27 | | | | | |
| Relative Return to S&P 500(%) | -33.69 | | | | | |
Michael King Ownership Network
Michael King Owned Company Details
What does SAB Biotherapeutics Inc do?
Who are the key executives at SAB Biotherapeutics Inc?
Michael King is the CHIEF FINANCIAL OFFICER of SAB Biotherapeutics Inc. Other key executives at SAB Biotherapeutics Inc include director & 10 percent owner & Chief Executive Officer Eddie Joe Sullivan , director & Executive Chairman Samuel J Reich , and director & 10 percent owner Christine E Hamilton .
SAB Biotherapeutics Inc (SABS) Insider Trades Summary
Over the past 18 months, Michael King made 1 insider transaction in SAB Biotherapeutics Inc (SABS) with a net purchase of 5,000. Other recent insider transactions involving SAB Biotherapeutics Inc (SABS) include a net purchase of 11,000 shares made by Samuel J Reich , a net purchase of 1,740 shares made by Eddie Joe Sullivan ,
In summary, during the past 3 months, insiders sold 0 shares of SAB Biotherapeutics Inc (SABS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of SAB Biotherapeutics Inc (SABS) were sold and 1,774 shares were bought by its insiders, resulting in a net purchase of 1,774 shares.
SAB Biotherapeutics Inc (SABS)'s detailed insider trading history can be found in Insider Trading Tracker table.
SAB Biotherapeutics Inc Insider Transactions
Michael King Mailing Address
Above is the net worth, insider trading, and ownership report for Michael King. You might contact Michael King via mailing address: 2100 East 54th Street North, Sioux Falls Sd 57104.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
